Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Kontinuerlig glukosemonitorering af patienter med type 1- og type 2-diabetes i dialysebehandling

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Natarbejde og komplikationer i graviditeten

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Donorsøgning til Hæmatopoietisk stamcelle transplantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Somatiske årsager til akut opståede psykiatriske tilstande hos børn og unge

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Magnesium sulphate treatment decreases the risk of cerebral palsy after preterm birth

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Treatment of monogenic disorders with viral transduced haematopoietic stem cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. One-year mortality increases four-fold in frail patients undergoing cardiac surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Adrenal insufficiency in kidney transplant patients during low-dose prednisolone therapy: a cross-sectional case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Studies indicate, that the glycated haemoglobin (HbA1c) level underestimates the mean blood glucose level in patients with Type 1- and Type 2 diabetes on haemodialysis. In patients receiving peritoneal dialysis the validity of HbA1c level is undetermined. Continuous glucose monitoring (CGM) could be an option for patients with diabetes receiving dialysis to assess the mean blood glucose level independently of the HbA1c level. In addition, CGM makes it possible to investigate periodic hypo- and hyperglycaemia and glucose variability. The evidence for the use of CGM in the dialysis population is limited but could represent an improved approach to glycaemic control.

Translated title of the contributionContinuous glucose monitoring of patients with type 1- and type 2 diabetes on haemodialysis
Original languageDanish
JournalUgeskrift for Laeger
Volume182
Issue number32
Pages (from-to)V03200166
ISSN0041-5782
Publication statusPublished - 3 Aug 2020

ID: 60985357